최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기생명과학회지 = Journal of life science, v.32 no.2, 2022년, pp.94 - 100
조자영 (국립수산과학원 생명공학과) , 이이조 (미얀마 의학연구국) , 성미소 (부산대학교 분자생물학과) , 정재훈 (부산대학교 분자생물학과)
Chronic infection by hepatitis B virus (HBV) greatly increases the risk for liver cirrhosis and hepatocellular carcinoma (HCC). The outcome of HBV infection is shaped by the complex interplay of the mode of transmission, host genetic factors, viral genotype, adaptive mutations, and environmental fac...
Akira, S., Isshiki, H., Sugita, T., Tanabe, O., Kinoshita, S., Nishio, Y., Nakajima, T., Hirano, T. and Kishimoto, T. 1990. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 9, 1897-1906.
Allweiss, L. and Dandri, M. 2017. The role of cccDNA in HBV maintenance. Viruses 9, 156.
An, P., Xu, J., Yu, Y. and Winkler, C. A. 2018. Host and viral genetic variation in HBV-related hepatocellular carcinoma. Front. Genet. 9, 261.
Beck, J. and Nassal, M. 2007. Hepatitis B virus replication. World J. Gastroenterol. 13, 48-64.
Belyhun, Y., Liebert, U. G. and Maier, M. 2018. Analysis of HBV basal core promoter/precore gene variability in patients with HBV drug resistance and HIV co-infection in Northwest Ethiopia. PLoS One 13, e0191970.
Block, T. M., Guo, H. and Guo, J. T. 2007. Molecular virology of hepatitis B virus for clinicians. Clin. Liver Dis. 11, 685-706.
Brunetto, M. R., Oliveri, F., Coco, B., Leandro, G., Colombatto, P., Gorin, J. M. and Bonino, F. 2002. Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study. J. Hepatol. 36, 263-270.
Buckwold, V. E., Xu, Z., Chen, M., Yen, T. S. and Ou, J. H. 1996. Effects of a naturally occurring mutation in the hepatitis B virus basal core promoter on precore gene expression and viral replication. J. Virol. 70, 5845-5851.
Chang, M. H. 2007. Hepatitis B virus infection. Semin. Fetal Neonatal Med. 12, 160-167.
Chong, C. L., Chen, M. L., Wu, Y. C., Tsai, K. N., Huang, C. C., Hu, C. P., Jeng, K. S., Chou, Y. C. and Chang, C. 2011. Dynamics of HBV cccDNA expression and transcription in different cell growth phase. J. Biomed. Sci. 18, 96.
Conjeevaram, H. S. and Lok, A. S. 2003. Management of chronic heaptitis B. J. Hepatol. 38, 90-103.
Costa, R. H., Kalinichenko, V. V., Holterman, A. X. and Wang, X. 2003. Transcription factors in liver development, differentiation, and regeneration. Hepatology 38, 1331-1347.
Custer, B. 2004. Global epidemiology of hepatitis B virus. J. ClinGastroenterol. 38, S158-168.
Datta S. 2008. An overview of molecular epidemiology of hepatitis B virus (HBV) in india. Virol. J. 5, 156.
Hsu, Y. S., Chien, R. N., Yeh, C. T., Sheen, I. S., Chiou, H. Y., Chu, C. M. and Liaw, Y. F. 2002. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 35, 1522-1527.
Hunt, C. M., McGill, J. M., Allen, M. I. and Condreay, L. D. 2000. Clinical relevance of hepatitis B viral mutations. Hepatology 31, 1037-1044.
Kamijo, N., Matsumoto, A., Umemura, T., Shibata, S., Ichikawa, Y., Kimura, T., Komatsu, M. and Tanaka, E. 2015. Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversion. World J. Gastroenterol. 21, 541-548.
Kao, J. H., Wu, N. H., Chen, P. J., Lai, M. Y. and Chen, D. S. 2000. Hepatitis genotypes and the response to interferon therapy. J. Hepatol. 33, 998-1002.
Lopez-Cabrera, M., Letovsky, J., Hu, K. Q. and Siddiqui, A. 1991. Transcriptional factor C/EBP binds to and transactivates the enhancer element II of the hepatitis B virus. Virology 183, 825-829.
McMahon, B. J. 2009. The natural history of chronic hepatitis B virus infection. Hepatology 49, S45-55.
Moriyama, K., Okamoto, H., Tsuda, F. and Mayumi, M. 1996. Reduced precore transcription and enhanced core-pregenome transcription of hepatitis B virus DNA after replacement of the precore-core promoter with sequences associated with e antigen-seronegative persistent infections. Virology 226, 269-280.
Poli, V. 1998. The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J. Biol. Chem. 273, 29279-29282.
Pollicino, T., Bellinghieri, L., Restuccia, A., Raffa, G., Musolino, C., Alibrandi, A., Teti, D. and Raimondo, G. 2013. Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha. Virology 444, 317-328.
Quarleri, J. 2014. Core promoter: a critical region where the hepatitis B virus makes decisions. World J. Gastroenterol. 20, 425-435.
Scaglioni, P. P., Melegari, M. and Wands, J. R. 1997. Biologic properties of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame. Virology 233, 374-381.
Tsai, A., Kawai, S., Kwei, K. Gewaily, D., Hutter, A., Tong, D. R., Li, J., Wands, J. R. and Tong, S. 2009. Chimeric constructs between two hepatitis B virus genomes confirm transcriptional impact of core promoter mutations and reveal multiple effects of core gene mutations. Virology 387, 364-372.
Wu, J. F. and Chang, M. H. 2015. Natural history of chronic hepatitis B virus infection from infancy to adult life-the mechanism of inflammation triggering and long-term impacts. J. Biomed. Sci. 22, 92.
Zheng, Y., Li, J. and Ou, J. H. 2004. Regulation of hepatitis B virus core promoter by transcription factors HNF1 and HNF4 and the viral X protein. J. Virol. 78, 6908-6914.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.